X0508 4 2023-08-01 1 0001828608 Compute Health Acquisition Corp. CPUH 0001333928 Watanabe Gwendolyn A C/O COMPUTE HEALTH ACQUISITION CORP. 1105 NORTH MARKET STREET, SUITE 1300 WILMINGTON DE 19890 1 0 0 0 0 Class A Common Stock 2023-08-01 4 A 0 21120 A 21120 D Class A Common Stock 2023-08-01 4 D 0 21120 D 0 D Class B Common Stock 2023-08-01 4 D 0 30000 D Class A Common Stock 30000 0 D Reflects transactions in connection with that certain Business Combination Agreement (the "Business Combination Agreement"), dated as of February 9, 2023 and amended as of May 2, 2023, by and among the issuer, Allurion Technologies Opco, Inc. (f/k/a Allurion Technologies, Inc.) ("Allurion"), Allurion Technologies, Inc. (f/k/a Allurion Technologies Holdings, Inc.) ("Pubco") and the other parties thereto (the "Business Combination"). Reflects the conversion of 30,000 shares of the issuer's Class B common stock, par value $0.0001 ("Class B Common Stock"), held by Ms. Watanabe into 21,120 shares of the issuer's Class A common stock, $0.0001 par value ("Class A Common Stock"), pursuant to the terms of that certain Sponsor Support Agreement, dated as of February 9, 2023, by and among the issuer, Compute Health Sponsor LLC, Allurion, Pubco and the other parties thereto, which was entered into in connection with the Business Combination. Pursuant to the terms of the Business Combination Agreement, each share of Class A Common Stock was canceled and converted into the right to receive 1.420455 shares of Pubco common stock, $0.0001 par value. As described in the issuer's registration statement on Form S-1 (File No. 333-252245) under the heading "Description of Securities--Founder Shares," the shares of Class B Common Stock were to automatically convert into shares of Class A Common Stock at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and had no expiration date. /s/ Joshua Fink, as attorney-in-fact 2023-08-03